000 | 01773 a2200529 4500 | ||
---|---|---|---|
005 | 20250517192050.0 | ||
264 | 0 | _c20180829 | |
008 | 201808s 0 0 eng d | ||
022 | _a2051-1426 | ||
024 | 7 |
_a10.1186/s40425-017-0301-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGroisberg, Roman | |
245 | 0 | 0 |
_aCharacteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials. _h[electronic resource] |
260 |
_bJournal for immunotherapy of cancer _c12 2017 |
||
300 |
_a100 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents, Immunological _xtherapeutic use |
650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMedical Records |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aSarcoma _xclassification |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aHong, David S | |
700 | 1 | _aBehrang, Amini | |
700 | 1 | _aHess, Kenneth | |
700 | 1 | _aJanku, Filip | |
700 | 1 | _aPiha-Paul, Sarina | |
700 | 1 | _aNaing, Aung | |
700 | 1 | _aFu, Siqing | |
700 | 1 | _aBenjamin, Robert | |
700 | 1 | _aPatel, Shreyaskumar | |
700 | 1 | _aSomaiah, Neeta | |
700 | 1 | _aConley, Anthony | |
700 | 1 | _aMeric-Bernstam, Funda | |
700 | 1 | _aSubbiah, Vivek | |
773 | 0 |
_tJournal for immunotherapy of cancer _gvol. 5 _gno. 1 _gp. 100 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s40425-017-0301-y _zAvailable from publisher's website |
999 |
_c27902641 _d27902641 |